Dietary supplementation evening primrose oil improve symptoms of fibromyalgia syndrome

Journal of Functional Foods

Volumn 5, Issue 3, 2013, Pages 1279-1287

  Montserrat de la Paz, Sergio ^a   García Giménez, Maria Dololores ^a   Ángel Martín, Maria ^a   Marín Aguilar, Fabiola ^a   Fernández Arche, Angeles ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Allodynia; Diet; Evening primrose; Fibromyalgia; Hyperalgesia; Inflammation

Indexed keywords

ANIMALIA; MUS; OENOTHERA; PRIMULA;

EID: 84880508725     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2013.04.012     Document Type: Article

References (50)

1. Allchorne A.J., Broom D.C., Woolf C.J. Detection of cold pain, cold allodynia and cold hyperalgesia in freely behaving rats. Molecular Pain 2005, 1:36.
2. Arranz L.I., Canela M.A., Rafecas M. Fibromyalgia and nutrition, what do we know?. Rheumatology International 2010, 30:1417-1427.
3. Belch J.J.F., Hill A. Evening Primrose oil and borage oil in rheumatological conditions. American Journal of Clinical Nutrition 2000, 71:352S-356S.
4. Blakeman K.H., Hao J.X., Xu X.J., Jacoby A.S., Shine J., Crawley J.N., Iismaa T., Wiesenfeld-Hallin Z. Hyperalgesia and increased neuropathic pain-like response in mice lacking galanin receptor 1 receptors. Neuroscience 2003, 117:221-227.
5. Calder P.C. The relationship between the fatty acid composition of immune cells and their function. Prostaglandins Leukotrienes and Essential Fatty Acids 2008, 79(3-5):101-108.
6. Chadman K.K., Gong S., Scattoni M.L., Boltuck S.E., Gandhy S.U., Heintz N., Crawley J.N. Minimal aberrant behavioral phenotypes of neuroligin-3 R451C knockin mice. Autism Research 2008, 1:147-158.
7. De Jong N., Klungel O.H., Verhagen H., Wolfs M.C., Ocké M.C., Leufkens H.G. Functional foods: The case for closer evaluation. BMJ 2007, 334(7602):1037-1039.
8. De la Puerta-Vázquez R., Martinez-Dominguez E., Sanchez-Perona J., Ruiz-Gutierrez V. Effects of different dietary oils on inflammatory mediators generation and fatty acid composition in rat neutrophils. Metabolism 2004, 53(1):59-65.
9. De las Heras B., Navarro A., Díaz-Guerra M.J., Bermejo P., Castrillo A., Boscá L., Villar A. Inhibition of NOS-2 expression in macrophages through the inactivation of NF-kappa B by andalusol. British Journal of Pharmacology 1999, 128:605-612.
10. Deng G.F., Lin X., Xu X.R., Gao L.L., Wang J.F., Li H.B. Antioxidant capacities and total phenolic contents of 56 vegetables. Journal of Functional Foods 2013, 5:260-266.
11. Donaldson M.S., Speight N., Loomis S. Fibromyalgia syndrome improved using a mostly raw vegetarian diet: An observational study. BMC Complementary and Alternative Medicine 2001, 1:7.
12. Engler M.M. Comparative study of diets enriched with evening primrose, black currant, borage or fungal oil on blood pressure and pressor responses in spontaneously hypertensive rats. Prostaglandins Leukotrienes and Essential Fatty Acids 1993, 49:809-814.
13. Fan Y.Y., Chapkin R.S. Importance of dietary gamma-linolenic acid in human health and nutrition. Journal of Nutrition 1998, 128:1411-1414.
14. Fan Y.Y., Ramos K.S., Chapkin R.S. Dietary gamma-linolenic acid suppresses aortic smooth muscle cell proliferation and modifies atherosclerotic lesions in apolipoprotein E knockout mice. Journal of Nutrition 2001, 1675-1681.
15. Fernández M.A., Tornos M., García M.D., de las Heras B., Villar A.M., Sáenz M.T. Anti-inflammatory activity of abietic acid, a diterpene isolated from Pimenta racemosa var. grissea. Journal of Pharmacy and Pharmacology 2001, 53:867-872.
16. Fernandez-Arche A., Marquez-Martin A., De la Puerta Vazquez R., Perona J.S., Terencio C., Perez-Camino C., Ruiz-Gutierrez V. Long-chain fatty alcohols from pomace olive oil modulate the release of proinflammatory mediators. Journal of Nutritional Biochemistry 2009, 20:155-162.
17. Green L.C., Wanger D.A., Glogowski J., Skipper P.L., Wishnok J.S., Tannenbaum S.R. Analysis of nitrate, nitrite, [15N]-nitrate in biological fluids. Analytical Biochemistry 1981, 126:131-138.
18. Gröticke I., Hoffmann K., Löscher W. Behavioral alterations in a mouse model of temporal lobe epilepsy induced by intrahippocampal injection of kainate. Experimental Neurology 2008, 213:71-83.
19. Hamburger M., Riese U., Graf H., Melziq M.F., Ciesielski S., Baumann D., Dittmann K., Wegner C. Constituents in evening primrose oil with radical scavenging, cyclooxygenase and neutrophyl elastase inhibitory activities. Journal of Agricultural and Food Chemistry 2002, 50:5533-5538.
20. Hänninen O., Kaartinen K., Rauma A.L., Nenonen M., Torronen R., Hakkinen A.S., Adlercreutz H., Laakso J. Antioxidants in vegan diet and rheumatic disorders. Toxicology 2000, 155:45-53.
21. Hibbeln J.R., Linnoila M., Umhau J.C., Rawlings R., George D.T., Salem N. Essential fatty acids predict metabolites of serotonin and dopamine in cerebrospinal fluid among healthy control subjects, and early- and late-onset alcoholics. Biological Psychiatry 1998, 44(4):235-242.
22. Hudson B.J.F. Evening primrose (Oenothera spp.) oil and seed. Journal of the American Oil Chemists' Soiety 1984, 61:540-543.
23. Inanici F., Yunus M.B. History of fibromyalgia: Past to present. Current Pain Headache Repents 2004, 8:369-378.
24. Jantti J., Nikkari T., Solakivi T., Vapaatalo H., Isomaki H. Evening primrose oil in rheumatoid arthritis: Changes in serum lipids and fatty acids. Annals of Rheumatic Disease 1989, 48:124-127.
25. Knorr R., Hamburger M. Quantitative analysis of anti-inflammatory and radical scavenging triterpenoid esters in evening primrose oil. Journal of Agricultural and Food Chemistry 2004, 11:3319-3324.
26. Lattancio V., Kroon P.A., Linsalata V., Cardinali A. Globe artichoke: A functional food and source of nutraceutical ingredients. Journal of Functional Foods 2009, 1:131-144.
27. Lawrence R., Helmick C., Arnett F.C., Deyo R.A., Felson D.T., Giannini E.H., Heyse S.P., Hirsch R., Hochberg M.C., Hunder G.G., Liang M.H., Pillmer S.R., Steen V.D., Wolfe K. Estimates of the prevalence of artritis and selected músculoskeletal disorders in the United States. Artritis Rheuatoid 1998, 41:778-799.
28. Mahady G.B., Fong H.H.S., Farnsworth N.R. In Botanical Dietary Supplements: Quality, Safety and Efficacy 2001, Sweets and Zeitlinger, Lissie, The Netherlands, pp. 75-85.
29. Maquet D., Croisier J.L., Crielaard J.M. Fibromyalgia in the year 2000. Revue Medicale de Liege 2000, 55:991-997.
30. Meves H. Arachidonic acid and ion channels: An update. British Journal of Pharmacology 2008, 155(1):4-16.
31. Montserrat-de la Paz S., Fernandez-Arche M.A., Angel-Martin M., Garcia-Giménez M.D. The sterols isolated from evening primrose oil modulate the release of proinflammatory mediators. Phytomedicine 2012, 19:1072-1076.
32. Navarro E., Alonso S.J., Navarro R. Toxicity and neuropharmacological effects of elenine. Evidence-Based Complementary and Alternative Medicine 2011, 1-10.
33. Nishiyori M., Ueda H. Prolonged gabapentin analgesia in an experimental mouse model of fibromyalgia. Molecular Pain 2008, 4:52-58.
34. Ozgocmen S., Ozyurt H., Sogut S. Current concepts in the pathophysilogy of fibromyalgia: the potential role of oxidative stress and nitric oxide. Reumatology International 2006, 26:585-597.
35. Pall M.L. Common etiology of posttraumatic stress disorder, fibromyalgia, chronic fatigue syndrome and multiple chemical sensitivity via elevated nitric oxide/peroxynitrite. Medical Hypotheses 2001, 57:139-145.
36. Pieczenik S.R., Neustadt J. Mitochondrial dysfunction and molecular pathways of disease. Experimental and Molecular Pathology 2007, 83:84-92.
37. Randall L.O., Selitto J.J. A method for measurement of analgesic activity on inflamed tissue. Archives Internationales de Pharmacodynamie et Therapie 1957, 111:409-419.
38. Salemi S., Rethage J., Wollina U., Michel B.A., Gay R.E., Gay S., Sprott H. Detection of interleukine 1 beta (IL-beta), IL-6, and tumor necrosis factor-alpha in skin of patients with fibromyalgia. The Journal of Rheumatology 2003, 30:146-150.
39. Sastry P.C. Lipids of nervous tissue: Composition and metabolism. Progress in Lipid Research 1985, 24(2):69-176.
40. Satyanarayana P.S., Jain N.K., Singh S., Kulkarni S.K. Effect of selective inhibition of cyclooxygenase-2 on lipopolysaccharide-induced hyperalgesia. Inflammopharmacology 2004, 12:57-68.
41. Simon P., Chermat R., Doaré L., Bourin M., Farinotti R. Unexpected interactions of some psychotropic drugs with barbital and pentobarbital effects in mice. Journal of Pharmacology 1982, 13:241-252.
42. Sulindro-Ma M., Ivy C.L., Isenhart A.C. Nutrition and supplements for pain management. Integrative pain medicine 2008, 417-445. Humana Press, USA. J.F. Audette, A. Bailey (Eds.).
43. Wallace D.J. Is there a role for cytokine based therapies in fibromyalgia. Current Pharmaceutical Design 2006, 12:17-22.
44. Wallace D.J., Linker-Israeli M., Hallegua D., Silverman S., Silver M.H., Weisman M.H. Cytokines play an aetiopathogenetic role in fibromyalgia: A hypothesis and pilot study. Rheumathology 2001, 40:743-749.
45. Weir P., Harlan G., Nikoy F., Jones S.S., Heqmann K.T., Gree L.H., Lyon J.L. The incidence of fibromyalgia and its associated comorbidities: A population-based retrospective cohort study based on international classification of diseases, 9th revision codes. Journal of Clinical Rheumatology 2006, 12:124-128.
46. Wiesenfeld-Hallin Z., Xu X.J., Crawley J.N., Hökfelt T. Galanin and spinal nociceptive mechanisms: recent results from transgenic and knock-out models. Neuropeptides 2005, 39:207-210.
47. Wolfe F., Ross K., Anderson J., Rusell I.J., Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Artritis Rheumatoid 1995, 38:19-28.
48. Wolfe F., Smythe H.A., Yunus M.B., Benett R.M., Bombardier C., Goldenberg D.L., Tuqwell P., Campbell S.M., Abeles S.M., Abeles M., Clark P. The American College of Rheumatology 1990 criteria for the classification of Fibromyalgia report of the multicenter criteria Committee. Arthritis Rheumatoid 1990, 33:160-172.
49. Young C., Gean P.W., Chiou L.C., Shen Y.Z. Docosahexaenoic acids inhibits synaptic transmission and epileptiform activity in the rat hippocampus. Synapse (New York, N.Y.) 2000, 37(2):90-94.
50. Zhang Z., Cherryholmes G., Mao A., Mare K., Longmate J., Kalos M., Amand R.P., Shively J.E. High plasma levels of MCP-1 and Eotaxin provide evidence for an immunological basis of fibromyalgia. Experimental Biologyand Medicine 2008, 2333:1171-1180.